Standard Biotools Stock Forward View - Accumulation Distribution
| LAB Stock | USD 1.26 0.02 1.61% |
Standard Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Standard Biotools stock prices and determine the direction of Standard Biotools's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Standard Biotools' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Standard Biotools' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Standard Biotools hype-based prediction, you can estimate the value of Standard Biotools from the perspective of Standard Biotools response to recently generated media hype and the effects of current headlines on its competitors.
Standard Biotools after-hype prediction price | USD 1.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections. Standard Biotools Additional Predictive Modules
Most predictive techniques to examine Standard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Standard using various technical indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 42262.42 | 0.0385 |
| Check Standard Biotools Volatility | Backtest Standard Biotools | Information Ratio |
Standard Biotools Trading Date Momentum
| On February 07 2026 Standard Biotools was traded for 1.26 at the closing time. Highest Standard Biotools's price during the trading hours was 1.30 and the lowest price during the day was 1.25 . There was no trading activity during the period 0.0. Lack of trading volume on the 7th of February did not result in any price rise and fall. The trading price change to current price is 1.59% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Standard Biotools to competition |
Other Forecasting Options for Standard Biotools
For every potential investor in Standard, whether a beginner or expert, Standard Biotools' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Standard Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Standard. Basic forecasting techniques help filter out the noise by identifying Standard Biotools' price trends.Standard Biotools Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Standard Biotools stock to make a market-neutral strategy. Peer analysis of Standard Biotools could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Standard Biotools Market Strength Events
Market strength indicators help investors to evaluate how Standard Biotools stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Standard Biotools shares will generate the highest return on investment. By undertsting and applying Standard Biotools stock market strength indicators, traders can identify Standard Biotools entry and exit signals to maximize returns.
Standard Biotools Risk Indicators
The analysis of Standard Biotools' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Standard Biotools' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting standard stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.09 | |||
| Semi Deviation | 3.33 | |||
| Standard Deviation | 4.47 | |||
| Variance | 19.99 | |||
| Downside Variance | 13.66 | |||
| Semi Variance | 11.09 | |||
| Expected Short fall | (3.99) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Standard Biotools
The number of cover stories for Standard Biotools depends on current market conditions and Standard Biotools' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Standard Biotools is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Standard Biotools' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Standard Biotools Short Properties
Standard Biotools' future price predictability will typically decrease when Standard Biotools' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Standard Biotools often depends not only on the future outlook of the potential Standard Biotools' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Standard Biotools' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 352.7 M | |
| Cash And Short Term Investments | 292.9 M |
Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.